Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!

Future GB logo

 

FUTURE-GB, an NIHR EME funded study, has opened with Southmead Hospital in Bristol as the first recruiting site.  Glioblastoma (GB) is the most common primary brain tumour and is incurable -with a poor prognosis for most patients. FUTURE-GB is a 2-stage trial, looking at the use of additional imaging technologies before and during adult glioblastoma surgery to improve patient outcomes and quality of life. Stage 1 of the trial is an IDEAL IIB study, with each patient receiving the additional imaging to ensure standardisation of practice with the technologies at each recruiting site. Stage 2 is the full randomised controlled trial, recruiting 357 participants from 15 neurosurgical centres across the UK. The whole trial will recruit for 33 months, and patient quality of life will be assessed for up to 2 years.

Similar stories

Clinical trial finds Azithromycin has no benefit against COVID-19

Main OCTRU

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

AVID-CC trial opens to recruitment!

OCTRU

The AVID-CC trial has received OCTRU Green Light approval and is now open to recruitment!

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research Trauma

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.

WHiTE Four trial results!

OCTRU

The WHiTE Four trial has now published its results in The Bone & Joint journal.

ARCADIAN trial opens to recruitment!

OCTRU

The ARCADIAN trial has received OCTRU Green Light approval and has now begun to open sites to recruitment!